Clinical study of Hematide in chronic renal failure patients not on dialysis
Phase 3
- Conditions
- Renal anemia
- Registration Number
- JPRN-jRCT2080221165
- Lead Sponsor
- Takeda Pharmaceutical Company Limited
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
1)The subject has chronic renal failure and is not on dialysis
2)The subject is capable of giving consent to participation in the study and understanding the informed consent form and other explanatory documents, and sings written consent.
etc.
Exclusion Criteria
1)The subject has received hemodialysis or peritoneal dialysis treatment
2)The subject is known to be intolerant to an iron preparation.
3)The subject has hemoglobinopathy (sickle cell disease, thalassemia, etc.).
4)The subject has any hemolytic disease or its past history.
etc.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method